| RS2145455397 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145455429 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145456711 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145457097 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145459429 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS2145460853 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145461096 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145461231 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2145461642 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2145462890 |
AP1G1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2145464604 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145464965 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145469964 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145469974 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145471381 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145471794 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145472327 |
AP1G1
|
Health Risk |
Pathogenic |
Usmani-Riazuddin syndrome, autosomal recessive |
| RS2145473620 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145474253 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145474267 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2145475371 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS2145476207 |
NFIX
|
Health Risk |
Likely pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS2145476311 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145476583 |
NFIX
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2145477468 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS2145477500 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145478387 |
PIGT
|
Health Risk |
Likely pathogenic |
— |
| RS2145478542 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145479013 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS2145479265 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS2145479494 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145479688 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145479791 |
NPC1
|
Health Risk |
Likely pathogenic |
— |
| RS2145480213 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145480909 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145480981 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2145480992 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2145481013 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2145481803 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145482327 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145482463 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145482955 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145483403 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145483535 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS2145484269 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145484584 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145484794 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145484822 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145485704 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS2145486022 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145486698 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2145487497 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145487524 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145487908 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145488506 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145491684 |
UBA2
|
Health Risk |
Pathogenic |
ACCES syndrome, ACCES syndrome |
| RS2145492068 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2145492753 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145492785 |
TNPO2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2145493702 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145495807 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145496104 |
TNPO2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2145496676 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145496726 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145497168 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2145497450 |
SLC12A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145497734 |
BRD4
|
Health Risk |
Pathogenic |
De Lange syndrome, Thyroid cancer |
| RS2145499914 |
BRD4
|
Health Risk |
Likely pathogenic |
Syndromic intellectual disability, Syndromic intellectual disability |
| RS2145500473 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145501058 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2145502127 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145503179 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145503665 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145503668 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2145503701 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145503914 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145503920 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145507682 |
SLC12A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 34 |
| RS2145512052 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145512343 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145512676 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145512909 |
EP300
|
Health Risk |
Likely pathogenic |
Menke-Hennekam syndrome 2, Menke-Hennekam syndrome 2 |
| RS2145513922 |
EP300
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2145515250 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, EP300-related disorder |
| RS2145516075 |
EP300
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2145516079 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145516424 |
EFTUD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2145516660 |
UBA2
|
Health Risk |
Pathogenic |
ACCES syndrome, ACCES syndrome |
| RS2145516989 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS2145517131 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS2145518271 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS2145519140 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS2145519321 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145522089 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS2145523848 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS2145524882 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS2145525133 |
AP1G1
|
Health Risk |
Pathogenic |
Usmani-Riazuddin syndrome, autosomal dominant |
| RS2145525136 |
AP1G1
|
Health Risk |
Pathogenic |
Usmani-Riazuddin syndrome, autosomal dominant |
| RS2145525235 |
AP1G1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usmani-Riazuddin syndrome, autosomal dominant |
| RS2145525803 |
LAMA3
|
Health Risk |
Pathogenic |
— |